Objective: Verify the efficacy of cognitive behavioral therapy (CBT) in adherence to the Mediterranean diet (MedDiet) in metabolic syndrome (MetS) patients. Design, Setting, Participants, and Intervention: In the Multimodal Intervention Program for Patients with Metabolic Syndrome clinical trial, 79 MetS patients completed the intervention. Of those, 48 belonged to the experimental group and 31 to the control group. The intervention received by the experimental group was CBT; the control group followed usual care and attended a workshop on healthy lifestyle. Main Outcome Measure(s) and Analysis: Anthropometric, biochemical, psychological, and lifestyle measures were taken before and after the intervention at 3 and 6 months. Analyses included paired t tests, ANOVA, and ANCOVA. Results: The ANOVA results showed a statistically significant interaction between the 2 groups in waist circumference (P = .009), triglycerides (P = .015), and adherence to the MedDiet (P = .026). The ANCOVA results indicated between-group difference in waist circumference (P = .026 and .062 at 3 and 6 months, respectively), in triglycerides (P = .009 and .860 at 3 and 6 months, respectively), and in MedDiet (P = .024 and .273 at 3 and 6 months, respectively). Conclusions and Implications: In interventions in which CBT was applied, significant improvements were observed in MetS patients, especially in adherence to the MedDiet.
INTRODUCTION
Metabolic syndrome (MetS) is the clustering of cardiovascular risk factors such as central obesity, atherogenic dyslipidemia, high blood pressure (BP) and hyperglycemia. 1 The best therapeutic strategy for MetS patients is the use of therapies that seek to reduce all risk factors simultaneously, such as lifestyle therapy. 2 Studies in this area indicate that behavioral intervention programs designed to promote healthy lifestyles, including physical exercise, nutritional education, and group dynamics are not only effective in producing changes in lifestyle but also directly influence biochemical outcomes. 3 Lifestyle modification based on cognitive behavioral therapy (CBT) is 1 of the most important and effective strategies for managing MetS, especially when specific recommendations regarding diet and exercise are combined with behavioral and cognitive strategies. The main challenge of this treatment lies in helping patients maintain healthy behavioral changes over the long term.
energy-deficit diets combined with reasonable long-term weight loss goals and increased physical activity is probably the most viable intervention method for reducing body weight. Cognitive behavioral techniques such as self-control, stimulus control, cognitive restructuring, relapse prevention, and the continuation of successful changes are critical to successful treatment. 5 In this regard, interventions focusing on adherence to the Mediterranean diet (MedDiet) are especially interesting. This diet is characterized by a high intake of fruits, vegetables, legumes, whole (minimally processed) foods, fish, and unsaturated fatty acids (especially olive oil); moderate consumption of alcohol (mainly wine, preferably consumed with food); and a low consumption of meat (particularly red meat), dairy products, and saturated fatty acids. 3 The Prevention with Mediterranean Diet study revealed that participants with greater adherence to the MedDiet had higher levels of high-density lipoprotein cholesterol (HDLc) and lower levels of triglycerides. It has been found that greater adherence to the MedDiet significantly lowers the likelihood of MetS in a population with a high risk for cardiovascular diseases (CVDs) 6 and can counteract the effects of increased adiposity on CVD risk. 7 Focusing on MetS patients, a few studies evaluated the effect of adherence to the MedDiet, including a clinical trial in which improvements were observed in the intervention group in weight, high-sensitivity C-reactive protein, and insulin resistance. 8 It would thus seem that adherence to the MedDiet is effective in reducing the prevalence of MetS and associated cardiovascular risk. 8 Despite these findings, to the authors' knowledge, no studies have performed a follow-up on the efficacy of CBT in increasing adherence to the MedDiet in MetS patients. This study was thus undertaken with a twofold objective: (1) to verify the efficacy of CBT in increasing adherence to the MedDiet, and (2) to study the cardiovascular risk factors modified as a consequence of implementing this therapeutic approach in a group of MetS patients, with a follow-up of 6 months.
METHODS

Design, Setting, and Participants
In the Multimodal Intervention Program for Patients with Metabolic Syndrome (clinical trial registered at clinicaltrials.gov, No. NCT02949622), 143 subjects who met the diagnostic criteria for MetS according to the National Cholesterol Education Program 1 were randomized to begin the intervention. Figure 1 shows a flowchart illustrating the progress of the patients over the course of the trial. Using intention-to-treat analysis, possible differences between subjects who completed the intervention and those who did not, such as differences in the main sociodemographic variables, lifestyle, and psychological traits were checked using Student t test and chisquare analysis.
Participants were blindly randomized into 2 groups. The first was the experimental group (EG) and the second was the control group (CG). A total of 79 participants (53.2% of whom were women) took part in the study, 48 in the EG and 31 in the CG. Table 1 shows the sample's main demographic variables.
Subjects were recruited over 2013À2014 from the University Hospital Virgen de las Nieves in Granada, Spain, which belongs to the Public Healthcare Service of Andalusia. This hospital serves approximately half of the population of the city of Granada and its province. All patients with a diagnosis of MetS who had consultations in the Hypertension or Rheumatology Departments during this period were assessed for possible inclusion in the study. Inclusion criteria were a diagnosis of MetS 1 according to the National Cholesterol Education Program: waist circumference > 88 cm for women and > 102 cm for men and the presence of 2 of the following characteristics: (1) BP: systolic 130 mm Hg and diastolic 85 mm Hg; (2) fasting glucose level 110 mg/dL; (2) triglycerides 150 mg/dL; and (4) high-density lipoprotein cholesterol (HDLc) 40 mg/dL in men and 50 mg/dL in women. Exclusion criteria were a diagnosis of advanced osteoarthritis, active inflammatory diseases, severe psychiatric disorders and/or significant cognitive impairment (assessed through the Mini Mental State Examination), and being illiterate. Patients aged <25 or >65 years were also excluded.
After reading the study information sheet, all subjects who participated in the trial gave informed consent in writing, following the principles of the Declaration of Helsinki. The research protocol was approved by the Ethical Committee of the University Hospital Virgen de las Nieves.
Intervention
The intervention program based on CBT, which had been assigned to the EG, consisted of the following sessions: (1) psychoeducation of the factors related to MetS and CBT; (2) dysfunctional thoughts and beliefs related to starting and maintaining a diet or exercise routine and difficulties that might hinder the process; (3) problem solving related to lifestyle change; (4) self-control and impulsivity when choosing food or planning an exercise routine; (5) stress management; (6) anger management; (7À9) social skills such as assertiveness, learning to say no effectively, and using feedback; (10) self-efficacy in relation to healthy eating and regular physical exercise; (11) social support from both family and health professionals; and (12) relapse prevention, with a view to promoting long-term maintenance of these changes.
The training was delivered by a psychologist in group format (ie, collectively), with 10À12 patients/group, during 12 weekly sessions lasting 90 minutes. Participation in the study was free of charge for the subjects. Four therapy groups were formed. The objectives of this intervention were to provide information about the disease and give patients cognitive strategies for both lifestyle changes and greater adherence to the proposed therapeutic measures.
The procedure followed for the CG consisted of a workshop with basic information about MetS and the cardiovascular risk involved. At the workshop, standard therapeutic measures were presented in accordance with the Nutrition, Physical Activity, and Prevention of Obesity Regarding intervention fidelity, the mean number of absences in the EG was 2.39 (SD, 1.44), and when a patient missed a session, its subject matter was covered again in the following session. All members of the EG group attended at least 80% of the intervention. All CG subjects attended a workshop. Both groups (EG and CG) started at the same time. Regarding pharmacological treatment, both groups continued the usual treatment during the intervention.
Main Outcome Measures
To test the efficacy of the intervention, all participants were evaluated 3 times: (1) before the sessions began (baseline), (2) at the end of treatment, and (3) after 6 months (follow-up evaluation). The primary outcomes (MetS components) were anthropometric, physiological, and biochemical measures (eg, weight and height to verify body mass index). Waist circumference was measured using a tape measure placed on a horizontal plane at the midpoint between the last rib and the iliac crest. Blood pressure was recorded according to the recommendations of the American Heart Association; 1 the mean of 3 readings taken at 2-minute intervals was used for analysis. Lipids (HDLc, total cholesterol, and triglycerides) and glycemic (fasting glucose) profiles were also taken.
The researchers analyzed secondary outcomes such as lifestyle habits using a demographic data sheet. This procedure was used to establish a profile of the sample evaluated. The level of physical activity was assessed in the initial interview; questions were related to the participant's exercise habits (eg, when, for how long, and how many times a week). The MedDiet adherence screener (MEDAS-14) was the measure used to evaluate the level of adherence to the MedDiet. This scale was developed for the Prevention with Mediterranean Diet (PREDIMED) 6, 7, 10 study and was widely used in Europe. The degree of adherence to the MedDiet was determined by summing the items as scored by the participant. Each item referred to the consumption of a particular food (for example, You use mainly olive oil for cooking), so each item reflected a self-reported behavior. A score <11 was considered low adherence whereas a score of 11 was high adherence. 10 The Fagerstr€ om Test for Nicotine Dependence 11 was used to evaluate the degree of dependence on nicotine.
The researchers also used psychological instruments such as the Mini Mental State Examination. This instrument was used because the study intended to assess the initial mental state of the patient and possible cognitive deficits. 12 In addition, the brief diagnostic Mini International Neuropsychiatric Interview, which was compatible with criteria in the Diagnostic and Statistical Manual of Mental Disorders, 5th edition and the International Classification of Diseases, 10th edition, 13 was used to evaluate possible comorbidities in the sample.
Procedure
After the participant signed the consent form, a structured interview was conducted in which the main demographic variables and anthropometric measures were obtained. Then the lifestyle and psychological assessment tools were administered. The procedure lasted approximately 2 hours and was divided into 2 parts, 1 for the interview and 1 to administer the questionnaires. All measurements were performed by a psychologist, except for the biochemical analyses, which the patient's regular doctor sent to be performed at the laboratory.
Patients were randomly assigned (1:1) to either the intervention group (CBT) or the CG. The subjects in the CG received their usual care and attended a workshop to promote healthy lifestyle habits.
Randomization was computer generated with blocks of 6 stratified by type of enrollment (type of consultation). An assistant not involved in the trial performed the randomization in the presence of the patient and the researcher.
Because of the nature of the study, patients were unblinded to the type of treatment they received (CBT vs workshop) but were kept unaware of the group to which they had been assigned; the researcher was unblinded for practical reasons. The researcher who obtained the baseline data was not blinded to the subject's group assignment, but the researcher who performed the posttreatment evaluation and follow-up evaluation was unaware of the group assignment. An independent researcher not involved in the study, who was also blinded to group assignment, performed the statistical analysis.
Statistical Analysis
G*Power (version 3.1.9.2, Universit€ at D€ usseldorf, D€ usseldorf, Germany, 2007) was used to confirm that for all analyses the number of participants was high enough to secure 95% power and a .05. Considering the existence of 2 groups and the need to compare data from 3 different times, G*Power determined that the total number of participants required was 44 (effect size f = 0.25 À medium).
A descriptive analysis was performed to explore the sample profile. Continuous variables were presented as means and SDs and categorical variables as frequencies and percentages. To see whether there were significant differences among the main demographic, anthropometric, lifestyle, and psychological variables, Student t tests (for independent samples) and chi-square tests (for categorical variables) were performed. Violations of normality were not found, because data for skewness and kurtosis values fell within acceptable ranges (skewness < j2.10j and kurtosis < j6.07j).
14 The researchers conducted a 2 £ 3 mixed ANOVA to check for statistically significant differences between the groups. The first factor included 2 levels (EG vs CG) between the independent groups. The second was a repeated-measures, within-subject factor at 3 times: baseline (MetS components and MedDiet); posttreatment (MetS components and MedDiet); and follow-up evaluation 6 months after treatment (MetS components and MedDiet). Sex was included as a covariable. The GreenhouseÀGeisser correction was applied in the repeatedmeasures analyses. When a significant group £ evaluation time interaction was found, the Bonferroni analysis was conducted to determine when such differences occurred. The Bonferroni analysis is a conservative post hoc procedure designed to compare different combinations while controlling the overall Type I error rate (a).
Lifestyle modifications promote a reduction in waist circumference and triglycerides in patients with metabolic syndrome.
According to the intention to treat analysis, using the last observation carry forward method, missing values were imputed and all randomized participants were included in repeatedmeasure ANOVA, adjusted by sex. For variables in which there was an interaction of time (baseline, 3 months, and 6 months) and group (EG and CG) in ANOVA, paired t tests were performed to check intragroup differences with the independent variable being the group with 2 levels (EG and CG) and the dependent variable being each of the anthropometric, biochemical, and lifestyle variables. Regarding the effect size, the partial h 2 value was used. This value indicates the effect size and should be compared with Cohen's guidelines (0.2 = small effect; 0.5 = moderate effect; and 0.8 = large effect). 15, 16 Finally, to check the efficacy of treatment between groups, an ANCOVA that was adjusted by sex and included baseline as a covariable was performed on waist circumference, triglycerides, and MedDiet. Regarding the effect size, the partial h 2 value was used for multivariate analysis (0.01 = small effect; 0.06 = moderate effect; and 0.14 = large effect). 15, 16 Data calculations were run with the assistance of SPSS software (version 21.0, SPSS, Inc, Armonk, NY, 2012).
RESULTS
Description of the Sample
The groups were comparable in terms of the main demographic variables, components of MetS, and pharmacotherapy, with the exception of waist circumference for women, as shown in Table 1 . The mean time since initial diagnosis (in years) was 4 (SD, 5) for fasting glucose, 8 (SD, 8) for hypertension, and 5 (SD, 6) years for dyslipidemia, respectively.
Intention-to-Treat Analysis
The results showed a statistically significant interaction between the groups for waist circumference ( 
Efficacy of CBT in Major Variables of MetS and Lifestyle
To check the efficacy of treatment, a mixed ANOVA was performed. Results showed a statistically significant interaction between groups in waist circumference (F 1,77 = 3.988; P = .031), triglycerides (F 1.77 = 4.867; P = .009), and adherence to the MedDiet (F 1,76 = 5,762; P = .011) in the posttreatment and 6-month followup evaluations (Figure 2) . No interaction was found in the other variables. In addition, ANOVA was repeated with adjustment by sex; results showed a statistically significant interaction between groups in waist circumference (F 1,76 = 5.612; P = .009, h Finally, to check the efficacy of treatment, the researchers performed an ANCOVA adjusted by sex and including baseline as a covariable. Results indicated a between-group difference in waist circumference at 3 months (F 1,75 = 5.153; P = .026; h Table 2 presents the results of subsequent intragroup and between-group analyses.
DISCUSSION
The aim of this study was to verify the efficacy of CBT in promoting adherence to the MedDiet and in reducing cardiovascular risk factors in patients with MetS. The results indicated differences between the EG and CG after treatment with CBT in some of the MetS criteria, such as the reduction in waist circumference and triglycerides for the EG. Regarding lifestyle variables, the EG also showed greater adherence to the MedDiet than did the CG after treatment.
Cognitive Behavior Therapy improved adherence to the Mediterranean diet of patients with metabolic syndrome.
The changes observed in the MetS criteria may be explained by adherence to the MedDiet, because this dietary pattern emphasizes foods that favor the reduction of fat centered in the abdomen and of hypertriglyceridemia. Other factors that may have contributed were an increase in physical exercise and changes in food in general, such as the type of food, quantity and frequency of consumption.
The reduction of 3 cm in the abdominal perimeter was clinically significant because it is the primary factor for the diagnosis of MetS according to Adult Treatment Panel III.
1 Also, a higher waist circumference is positively associated with higher mortality; 3 each 5-cm increment in waist circumference is associated with a 7% increase in mortality risk for men and a 9% increase in mortality risk for women, 17 which underlines the importance of making lifestyle changes aimed at reducing it.
Differences were observed in triglycerides but not in HDLc or glucose. The results of a study conducted in the same area of research showed that a lifestyle intervention program with MetS patients who had received instructions on the MedDiet and a regular aerobic exercise routine had significant improvements in waist circumference, BP, and HDLc, but limited effects on glucose and triglyceride levels compared with the usual care received. 18 However, in this study, differences were observed in triglycerides but not in HDLc or glucose. It seems that interventions with similar objectives may have different effects in subjects with MetS.
These findings also agreed with the proposal that highlighted the role of the MedDiet combined with behavioral counseling. Specifically, there was a significant improvement in weight compared with a low-fat diet. In addition, the combination of diet and exercise and/or behavioral counseling resulted in a significant reduction in hypertension, which could be seen as an improvement in the risk for MetS and diabetes compared with untreated CGs. 19 In this study, the importance of a healthy lifestyle was emphasized at every session. Specifically, the MedDiet dietary pattern was recommended to modify eating habits.
Other studies corroborated these results in relation to possible improvements in MetS criteria and provided information on criteria less susceptible to change. The duration of the treatment used in this study may be considered within the range necessary to observe potential changes, according to some studies. 20 Considering the profile of interventions in a systematic review, it was found that lifestyle modification programs can effectively reduce triglyceride levels, waist circumference, and systolic BP. However, few trials consistently confirmed the benefits for metabolic risk and none revealed a significant effect on HDLc or fasting plasma glucose. The duration of the programs ranged from 4 to 24 weeks, and a duration of 12 weeks was found to improve quality of life significantly. 20 Nevertheless, there are studies that partially coincided with the current results regarding changes in the components of MetS, in particular in the reduction of waist circumference. However, in participants who had completed at least 6 out of 8 sessions of a healthy lifestyle program over 12 months, nearly 90% showed increased health knowledge and at least 60% showed reduced risk factors associated with MetS such as glycemia, cholesterol, body mass index, and waist circumference. 21 To the best of the authors' knowledge, no previous interventions with CBT have studied the efficacy of the MedDiet in patients with MetS. CG indicates control group; EG, experimental group. *P < .05 in intragroup analysis; **P < .001 in intragroup analysis; ***P < .05 in between-group analysis; ****P < .01 in betweengroup analysis.
However, studies were located that demonstrated the effectiveness of adherence to the MedDiet in MetS components such as decreased waist circumference, triglycerides, fasting glucose, and systolic and diastolic BP. Studies performed in Europe using behavioral techniques and in small groups were located that showed significant benefits when the intervention was of longer duration. 22 Adherence to the MedDiet was associated with a lower risk for MetS (waist circumference, hypertension, triglycerides, and HDLc). 23, 24 In addition, the PREDIMED trial provided strong evidence that the MedDiet may be a sustainable and ideal model to prevent of CVD 25 and MetS.
26À28
It is well known that the prevalence of the metabolic parameters that make up MetS can be reduced by lifestyle changes. 29 However, it is vital that this awareness not remain at the merely educational level: instead, patients' cognitions, emotions, and behaviors must also be addressed in an effort to increase effectiveness. 29 In this regard, Ramic et al 29 pointed out that the fundamental problem is not the lack of effectiveness of available therapeutic measures such as medication and treatments, but rather their insufficient application. With early detection of MetS risk factors, it is likely that reductions will be seen not only in childhood incidence but also in prevalence in the adult population. 30 The main limitation of this study was that it lacked a measure to evaluate physical activity. Also, future studies might observe patients for longer periods to see whether they were maintaining changes in the long term, because without treatment patients lost some of the effects observed at the end of the program, and weight loss, for example, tends to stabilize regardless of the treatment strategy used. The CBT intervention led to greater compliance with the MedDiet and also to an improvement in waist circumference and triglycerides at 3 months. However, this effect was not sustained at 6 months. Specifically, the effect on waist circumference was marginally significant and effects on compliance with the MedDiet and triglycerides were not significant at 6 months. For this reason, long-term recall sessions are recommended, although definitive data are not available on the duration and optimal intensity of the maintenance phase. 4 Furthermore, in relation to future prospects, special emphasis might be placed on the mediating factors of lifestyle change, especially CBT. This could be done with a view to defining cognitive, behavioral, and lifestyle factors (the MedDiet or other dietary patterns and physical exercise) and also the role of gender and the duration of the intervention and its format (group or individual).
In this study, which consisted of a 3-month intervention with weekly contact between the health professional and the patient, using a smallgroup format and applying CBT, significant improvements were observed in patients with MetS and in their lifestyle, especially adherence to the MedDiet. These results have important implications not only in terms of research but also in clinical settings, because reducing risk factors for MetS is a primary therapeutic goal and a significant challenge for health professionals.
With a 3-month intervention, significant improvements may be observed in patients with metabolic syndrome.
IMPLICATIONS FOR RESEARCH AND PRACTICE
The results of this study highlight the value of CBT as a tool to change dietary habits, especially those related to adherence to the MedDiet, and consequently to reduce cardiovascular risk factors. At the public health level, the cost of prevention and treatment (the number of medical visits or operations performed on patients with high cardiovascular risk) could be reduced. Therefore, CBT in a group format and with a multidisciplinary team can have positive implications for the cost-effectiveness of managing this disease. Future studies might investigate the role that CBT can have in lifestyle modifications in different clinical populations, in adherence to other dietary patterns, and in relation to a longer follow-up.
